MORGAN STANLEY

Holdings History for Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

Symbol: NERV on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$44,441	11,055	+47	+0.43%	$4.02	Q4 2025
30 Sep 2025	0%	0%	$23,172	11,008	0		$2.11	Q3 2025
30 Jun 2025	0%	0%	$18,933	11,008	+4	+0.04%	$1.72	Q2 2025
31 Mar 2025	0%	-0%	$18,707	11,004	-5,100		$1.70	Q1 2025
31 Dec 2024	0%	+0%	$35,777	16,104	+5,357		$2.22	Q4 2024
30 Sep 2024	0%	0%	$28,694	10,747	0		$2.67	Q3 2024
30 Jun 2024	0%	0%	$34,283	10,747	0		$3.19	Q2 2024
31 Mar 2024	0%	+0%	$27,728	10,747	+4,461	+71%	$2.58	Q1 2024
31 Dec 2023	0%	-0%	$38,659	6,286	-7,319	-54%	$6.15	Q4 2023
30 Sep 2023	0%	+0%	$93,875	13,605	+4,610	+51%	$6.90	Q3 2023
30 Jun 2023	0%	0%	$82,215	8,995	+420	+4.9%	$9.14	Q2 2023
31 Mar 2023	0%	0%	$13,720	8,575	-100	-1.2%	$1.60	Q1 2023
31 Dec 2022	0%	-0%	$13,793	8,675	-4,944	-36%	$1.59	Q4 2022
30 Sep 2022	0%	+0%	$126,000	13,619	+6,627	+95%	$9.25	Q3 2022
30 Jun 2022	0%	+0%	$23,000	6,992	+6,992	NEW	$3.29	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.